GAMMA Investing’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GAMMA Investing's LKFT Position: Q3 2026 in Review
GAMMA Investing increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 175% in Q3 2026, buying an estimated $48K and bringing the position to 2,628 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2057.
GAMMA Investing first reported a position in LKFT in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- GAMMA Investing held 2,628 shares of Lakefront Biotherapeutics American Depositary Shares worth $77.9K as of Q3 2026.
- GAMMA Investing bought 1,674 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $48K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2057 holding.
- GAMMA Investing first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2023 and has held it in 12 quarters since.
- 8 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.